Assenagon Asset Management S.A. Syndax Pharmaceuticals Inc Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 466,028 shares of SNDX stock, worth $6.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

466,028

Previous 428,949 8.64%

Holding current value

$6.1 Million

Previous $8.81 Million 1.87%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$17.93 - $24.81 $664,826 - $919,929	37,079 Added 8.64%	466,028 $8.97 Million
Q2 2024 Jul 18, 2024	BUY	$18.82 - $23.79 $2.84 Million - $3.59 Million	151,021 Added 54.34%	428,949 $8.81 Million
Q1 2024 Apr 24, 2024	SELL	$19.71 - $24.57 $2.64 Million - $3.29 Million	-134,037 Reduced 32.54%	277,928 $6.61 Million
Q4 2023 Jan 17, 2024	BUY	$11.39 - $21.67 $244,053 - $464,323	21,427 Added 5.49%	411,965 $8.9 Million
Q3 2023 Nov 06, 2023	BUY	$14.52 - $21.77 $1.83 Million - $2.74 Million	125,893 Added 47.57%	390,538 $5.67 Million
Q2 2023 Jul 25, 2023	SELL	$19.35 - $22.31 $1.45 Million - $1.67 Million	-74,947 Reduced 22.07%	264,645 $5.54 Million
Q1 2023 Apr 18, 2023	BUY	$20.66 - $28.98 $6.81 Million - $9.55 Million	329,577 Added 3290.83%	339,592 $7.17 Million
Q4 2022 Jan 12, 2023	SELL	$20.64 - $26.24 $208,587 - $265,181	-10,106 Reduced 50.23%	10,015 $255,000
Q3 2022 Oct 27, 2022	SELL	$18.51 - $24.79 $3.53 Million - $4.73 Million	-190,623 Reduced 90.45%	20,121 $484,000
Q2 2022 Jul 27, 2022	BUY	$13.64 - $19.48 $2.87 Million - $4.11 Million	210,744 New	210,744 $4.06 Million
Q1 2022 Apr 25, 2022	SELL	$14.84 - $22.15 $4.21 Million - $6.29 Million	-283,954 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$15.23 - $22.47 $4.32 Million - $6.38 Million	283,954 New	283,954 $6.22 Million
Q4 2020 Feb 01, 2021	SELL	$15.1 - $26.44 $2.56 Million - $4.49 Million	-169,792 Closed	0 $0
Q3 2020 Oct 07, 2020	SELL	$13.39 - $17.48 $112,476 - $146,832	-8,400 Reduced 4.71%	169,792 $2.51 Million
Q2 2020 Jul 21, 2020	BUY	$8.94 - $20.98 $1.59 Million - $3.74 Million	178,192 New	178,192 $2.64 Million

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Syndax Pharmaceuticals Inc Transaction History